Aopumai: Revenue in the first half of 2026 reached 450 million yuan, a year-on-year increase of 153%.

Aoupumai announced that it is expected to achieve operating income of approximately 450 million yuan in the first half of 2026, an increase of 153% year-on-year; it is expected to achieve a net profit attributable to the owners of the parent company of approximately 124 million yuan, an increase of 229% year-on-year; it is expected to achieve a non-recurring net profit of approximately 49 million yuan, an increase of 64% year-on-year. The performance growth is mainly due to the completion of the transfer of assets of Pengli Biology in January and its inclusion in the consolidated financial statements. Pengli Biology contributed revenue of approximately 220 million yuan and a net profit of approximately 30 million yuan; the company's original business revenue was 230 million yuan, an increase of over 30% compared to the same period last year.